CA-15.3
₹1200
This assay is useful for predicting early recurrence in women treated for Carcinoma Breast. It is specially useful for serial testing in women with prior Stage II / III breast cancer who are clinically free of disease.
Test information: Fasting not necessary, but preferred
Reporting: Within 48 hours*
- Fasting is not necessary but preferred.
* For details, please see service-related policies
Talk to Health Expert
Health Articles
PET vs CT Scan: Differences, Uses
📅 09 Sep, 2026 | ✍️ By Molecular Diagnostics and Therapy LLP
Pregnancy Problems: Causes, Symptoms, Types & Tes…
📅 09 Sep, 2026 | ✍️ By Molecular Diagnostics and Therapy LLP
FDG PET Scan in Lymphoma Management
📅 08 Sep, 2026 | ✍️ By Molecular Diagnostics and Therapy LLP
Endometriosis: Causes, Symptoms, Types & Tests
📅 08 Sep, 2026 | ✍️ By Molecular Diagnostics and Therapy LLP